Tuesday, October 22nd, 2019
Rapid advancements in cell and gene therapy development have resulted in recent product approvals bringing these transformative medicines to market. Commercializing these products have introduced a new set of challenges unique to our industry.
Single-Use products and systems have proven to enable a more flexible and cost-effective approach to traditional bio-pharma manufacturing when certain manufacturing modifications are adopted. For example, using low volume sample management systems to increase product yields and implementing ready to use sterilized solution prefilled to certain amount for addition to each step in a closed loop fashion. These new products can be used to streamline the process with consistent quality output.